Particle Dynamics expands to upgrade CDMO services


New innovation centre includes development laboratories and pilot-scale processing rooms for spray drying, microencapsulation, continuous granulation, and solid dosage form development

Technologies from Particle Dynamics

Technologies from Particle Dynamics

Particle Dynamics has completed its new Product and Process Innovation Center located within its US-based, St Louis facilities. The completion of the strategic expansion marks a milestone in Particle Dynamics' transformation to an integrated solution-provider serving the nutraceutical, OTC, consumer health, and pharmaceutical sectors.

The investment in facilities and talent further aligns the company's innovation and manufacturing resources to more rapidly meet the demanding needs for more innovative functional materials and dosage forms without compromising compliance track record.

The new, fully integrated innovation centre includes development laboratories and pilot-scale processing rooms housing technologies in Spray Drying, Microencapsulation, Continuous Granulation, and Solid Dosage Form Development. Designed for a fully integrated and seamless transition of new products to commercial scale, the new innovation centre will streamline process development and enable more rapid commercialisation of products into either of the company's FDA inspected, GMP facilities in St Louis, MO and Seymour, IN.

In addition to the facility and equipment investments, Particle Dynamics has developed a project management infrastructure, and hired leaders in Technical Operations, Innovation, and Sales to fuel the company's next level of growth; supporting customer success aligned with current market trends.

Sign up for your free email newsletter

"This investment is fully aligned with our Vision to provide a fully integrated portfolio of products and services to the global Healthcare industry," said Nicolas Fortin, CEO of Particle Dynamics. "Having advanced technologies such as spray drying, microencapsulation, granulation, and advanced dosage form development under one roof will enable us to more rapidly respond with the right technical solutions to meet the needs of our customers."